Table Of Content

2006 Subject Index Cutaneous Malignancies: BCC, SCC, and MM, 183 continued from page 610 Cutaneous Malignancies: KA, CTCL, and KS, 270 Cutaneous Manifestations of Systemic Disease: Cancer Leukemia/Lymphoma, Systemic Malignancy, Cutaneous Leiomyomas: A Clinical Marker of Risk for Hypothyroidism, Diabetes Mellitus, and Hereditary Leiomyomatosis and Renal Cell Cancer, Neurofibromatosis, 476 335 Dermatitis/Eczemas, 69 Living with Skin Cancer, (id Dermatology Nursing News Case Study 89, 185, 281, 392, 499, 611 Assessing Phytophotodermatitis: Boy with Erythema and Blisters on Both Hands, 153 Disease Management Calcipotriol (Dovobet*) Ointment in Combination with Clinical Skills UVB Therapy for Psoriasis Treatment, 258 Allergens of New and Emerging Significance, 545 Case Study on Linear Focal Elastosis, 469 Case Study: Intensely Pruritic, Diffuse Erythematous, Psoriasis: Disease Management with a Brief Review of Scaly Patches, 304 New Biologies, 40 Treatment of Cutaneous T Cell Lymphoma/Mycosis Clinical Snapshot Fungoides, 566 Allergic Contact Dermatitis, 48 Atopic Dermatitis, 580 From the Editor Basal Cell Carcinoma, 584 Body Dysmorphic Disorder: Implications for Practice, Connective Tissue Nevus, 105 13 Dermagraphism, 263 Dermatology Nursing Recognized for Quality and Erythema Multiforme, 489 Professionalism, 421 Guttate Psoriasis, 309 iPLEDGE: Protecting Patients or Prohibiting Access to Intracorneal Hemorrhage, 373 Care?, 124 Juvenile Xanthogranuloma, 51 More Advances for Dermatology Patients, 529 Lichen Sclerosus et Atrophicus, 264 Recognizing a New Public Health Concern, 326 Livedo Reticularis in Antiphospholipid Antibody Take the First Step, Experience New Journeys, 225 Syndrome, 46 Pityriasis Rosea, 370 Immunity Challenge Pyoderma Gangrenosum, 482 Did You Say ‘Taxes’ or ‘Texas’?, 268 Scabies, 588 Of Primary Importance, 368 Skin Rashes in a Patient with Antibodies to Ro/SS-A, The Keratinocyte, 182 168 Where Did All of the Windows Go?, 472 Tinea Versicolor, 167 Letter to the Editor Continuing Nursing Education PRP Support Group, 28 A Comprehensive Management Guide for Atopic Dermatitis, 531 Literature Review Allergic Contact Dermatitis to Preservatives, 130 Chicken Soup for the Nurse’s Soul, 494 Autoimmune Bullous Diseases: Diagnosis and Clinical Experience with Long-Term Use of Biologic Management, 20 Agents: Efficacy, 181 Cutaneous Leiomyomas: A Clinical Marker of Risk for Laser Surgery Techniques, 629 Hereditary Leiomyomatosis and Renal Cell Cancer, Poster Presentation, 269 335 Skin Self-Examinations, 64 Diagnostic Signs and Symptoms of Psoriatic Arthritis, Streamlining Adverse Event Reporting in Trials, 381 S7 Sun Protection for Life, 629 Overview of Hepatitis C and Skin, 425 Which Patient, Which Agent, and Why?, 181 The Morbidity of Psoriatic Disease, S4 The Rheumatology/Dermatology Collaboration, SIO Management Forum Treating Itch in Psoriasis, 227 How to Recruit, Interview, and Retain Employees, 179 Update on Antimicrobial Resistance, 15 Nurses Involvement with Strategic Planning, 63 The Right Staff: A Primer of Practice for Medical Dermatology Nursing Essentials: Core Knowledge Assistants and Aestheticians, 475 Benign Neoplasms/Hyperplasia, 377 DERMATOLOGY NURSING/December 2006/Vol. 18/No. 6 615 New Products The Morbidity of Psoriatic Disease, S4 83, 300, 383, 491, 609 The Rheumatology/Dermatology Collaboration, SIO Treating Itch in Psoriasis, 227 On Leadership Authentic Leadership, 595 Research Allow Yourself to Be Surprised, 72 Barriers to Addressing Patient Sexuality in Nursing Establishing Guardrails in Leadership, 293 Practice, 448 Megatrends, The Annual Report, Possibilities, 386 Skin Breakdown in Acute Care Pediatrics, 155 The Johnny Appleseeds of Organizational Change, 208 Specialized Education for Patients with Psoriasis: A Patient Survey on its Value and Effectiveness, 358 Patients’ Perspectives The Causes of Acne: A Qualitative Study of Patient Living with Skin Cancer, 66 Perceptions of Acne Causation and Their Implications for Acne Care, 344 Pharmacology Review The Results and Side Effects of Systemic Isotretinoin Paroxedne May Cause Increase Risk for Congenital Treatment in 100 Patients with Acne Vulgaris, 576 Malformahons, 68 Supplement Phototherapy Diagnostic Signs and Symptoms of Psoriatic Arthritis, Calcipotriol (Dovobet*) Ointment in Combination with S7 UVB Therapy for Psoriasis Treatment, 258 The Morbidity of Psoriatic Disease, S4 The Rheumatology/Dermatology Collaboration, SIO Procedures in Therapeutics Acne Scarring; Current Treatment Options, 139 What’s Your Assessment? Cutaneous Cryosurgery, 456 30, 145, 244, 357, 445, 563 Professional Practice Wound Assessment and Evaluation Paleodermatology Update, 245 Aging Skin and Wound Healing, 265 Update on Preparing for the Next Influenza Pandemic, Tt Hurts When I Walk’; Venous Stasis Disease - 363 Etiology and Assessment, 480 ‘It Hurts When I Walk’: Venous Stasis Disease - Psoriasis Diffirential Diagnosis and Treatment, 582 Calcipotriol (Dovobet") Ointment in Combination with Neuropathic Ulcers: Diabetes and Wounds, Part I. UVB Therapy for Psoriasis Treatment, 258 Etiology and Assessment, 52 Diagnostic Signs and Symptoms of Psoriatic Arthrihs, S7 Neuropathic Ulcers; Diabetes and Wounds, Part II. Guttate Psoriasis, 369 Differential Diagnosis and Treatment, 163 Psoriasis: Disease Management with a Brief Review of New Biologies, 40 Advertisers’ Index Clinical Snapshot-Scabies continued from page 588 Abbott Laboratories, Inc. Intendis, Inc. Humira. 521-524 Finacea. 516-517 eyes and mucous membranes during applicahon. It is Humira. 589-594 highly recommended to instruct patients to wash bed Merz Pharmaceuticals Amgen, Inc. Aqua Glycolic. .... 530 linens, clothing, and towels in hot water or have them dry Enbrel. 549-554 appearex. .... 565 cleaned to kill the scabies mite. It is also recommended to decontaminate other personal items. All family members APIC OrthoNeutrogena and close contacts of those diagnosed with scabies must Think TB. .... 631 Retin-A Micro. 598-600 receive treatment. Collagenix Pharmaceuticals. Inc. Pharmaderm Nursing Measures: Instnicting patients on the proper Oracea. .611-614 Cutivate. 561-562 use of prescribed medications and their respective side effects are two of the many measures nurses must make. Connetics Corp. Stiefel Laboratories, Inc. Evoclin. .571-572 ZNPBar. ....518 Nursing staff can suspect scabies when there is a history of Sarna Ultra. .... 528 pruritus in other family members or caregivers of a padent Coria Laboratories Zeasorb-AF. .... 544 with scabies. Moreover, nurses must be aware of Id reac¬ CeraVe. .... 526 Sarna Sensitive. .... 581 PanOxyi Bar. .... 609 tions, or autoeczematization, a generalized acute cutaneous Galderma Laboratories Sarna Original. .... 628 reaction characterized by a pruritic rash. Id reactions can Cetaphil.Back Cover occur when patients are infected with parasites such as the University of San Diego arachnid mite in scabies. □ Autoimmune Diseases in Pregnancy. .... 597 616 DERMATOLOGY NURSING/December 2006/Vol. 18/No. 6 "4 ■ J I -3P-